Exelixis Inc
(NAS:EXEL)
$
36.115
0.265 (0.74%)
Market Cap: 10.31 Bil
Enterprise Value: 9.21 Bil
PE Ratio: 23.15
PB Ratio: 4.54
GF Score: 91/100 Exelixis Inc at Oppenheimer Healthcare Life Sciences Conference Transcript
Feb 13, 2024 / 05:40PM GMT
Release Date Price:
$20.23
(-0.78%)
Jay Olson
Oppenheimer & Co. Inc., Research Division - Executive Director & Senior Analyst
Hello everyone and welcome to Oppenheimer's 34th Annual Healthcare Conference. I'm Jay Olson, 1 of the biotech analysts at Oppenheimer, and I want to thank you all for joining us here today. It's my pleasure to welcome Exelixis to our conference, and it's an honor to introduce Varant Shirvanian from IR and Andrew Peters, Head of Strategy. If you guys have any questions during this discussion, please feel free to submit them using the Q&A function. And with that, we'll get started. Thank you so much, Andrew and Varant, for joining us today.
Andrew Ross Peters
Exelixis, Inc. - SVP of Strategy
Yes. Thank you. Thanks for the invitation.
Questions & Answers
Jay Olson
Oppenheimer & Co. Inc., Research Division - Executive Director & Senior Analyst
It's our pleasure. So maybe for those in our audience who aren't fully up to speed with the Exelixis story. Do you want to get us started with kind of maybe
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot